IL6 and neoplasm: Therefore the production of IL-6 and IL-10 [which activates the immune-suppressive and tumor-promoting effects of Gr-1+ CD11b+ IMCs via STAT3 and STAT6 signaling (46–48)] by licofelone-treated cells differentiated under IMC-inducing conditions was examined.